Suppr超能文献

共晶体10-(2-甲基-4-苯基-1H-茚-6-基)-10H-吩噻嗪-10-(2-甲基-7-苯基-1H-茚-5-基)-10H-吩噻嗪(0.54/0.46)

The cocrystal 10-(2-methyl-4-phenyl-1H-inden-6-yl)-10H-phenothia-zine-10-(2-methyl-7-phenyl-1H-inden-5-yl)-10H-phenothia-zine (0.54/0.46).

作者信息

Nikulin Mikhail V, Voskoboynikov Alexander Z, Suponitsky Kyrill Yu

出版信息

Acta Crystallogr Sect E Struct Rep Online. 2008 Nov 13;64(Pt 12):o2317. doi: 10.1107/S1600536808036210.

Abstract

The title compound, 0.535C(28)H(21)NS.0.465C(28)H(21)NS, was synthesized by palladium-catalysed amination. The structure is composed of two isomeric mol-ecules, viz. 10-(2-methyl-4-phenyl-1H-inden-6-yl)-10H-phenothia-zine, and 10-(2-methyl-7-phenyl-1H-inden-5-yl)-10H-phenothia-zine, in the refined ratio 0.535 (12):0.465 (12). The isomers differ by the localization of the double bond in the cyclo-penta-diene ring. There are two sites in the structure that are occupied by the isomers. The respective isomers are occupationally disordered in each site, the refined proportions being 0.640 (6):0.360 (6) and 0.43 (1):0.57 (1). Moreover, each isomeric mol-ecule is chiral; due to the crystallographic centres of symmetry, the mol-ecules are also present in enanti-omeric pairs. The crystal structure is stabilized by weak π-π [C⋯C = 3.389 (2) Å] inter-actions.

摘要

标题化合物0.535C₂₈H₂₁NS·0.465C₂₈H₂₁NS通过钯催化胺化反应合成。其结构由两个异构体分子组成,即10-(2-甲基-4-苯基-1H-茚-6-基)-10H-吩噻嗪和10-(2-甲基-7-苯基-1H-茚-5-基)-10H-吩噻嗪,精制比例为0.535(12):0.465(12)。异构体的区别在于环戊二烯环中双键的位置。结构中有两个位置被异构体占据。各自的异构体在每个位置上存在占位无序,精制比例为0.640(6):0.360(6)和0.43(1):0.57(1)。此外,每个异构体分子都是手性的;由于晶体学对称中心,分子也以对映体对的形式存在。晶体结构通过弱π-π[C⋯C = 3.389(2) Å]相互作用得以稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1947/2959856/53fdbdb953a8/e-64-o2317-fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验